Attention-enabled Explainable AI for Bladder Cancer Recurrence Prediction

Improved prediction accuracy with clinical relevance: The model achieves 70% accuracy in predicting bladder cancer recurrence, outperforming conventional statistical methods. This is significant given that existing clinical tools often overestimate recurrence risk, potentially leading to unnecessary procedures for the 460,000 individuals worldwide affected by non-muscle-invasive bladder cancer.

Explainability enables personalized patient care: The attention mechanism provides "patient-specific insights by highlighting the most influential features contributing to recurrence risk for each patient," allowing clinicians to understand why the model makes specific predictions rather than treating it as a "black box." This transparency is essential for clinical adoption and informed decision-making.

Captures complex relationships missed by traditional methods: By using vector embeddings for categorical variables like smoking status and intravesical treatments, the model identifies "new important factors influencing recurrence, such as surgical duration" that conventional approaches may overlook, potentially revealing previously underappreciated clinical insights.

Addresses real clinical burden: With recurrence rates reaching 70-80% and each recurrence triggering "invasive procedures, lifelong surveillance, and escalating healthcare costs," better prediction tools have direct implications for reducing patient harm and healthcare burden—making responsible AI development in this domain particularly consequential.

Maintains clinician-friendly interpretability at scale: The framework balances improved performance with accessibility, providing "clinician-friendly patient-level explanations" rather than requiring medical professionals to become machine learning experts to validate and use the tool.